Team:HKUST-Hong Kong/overview.html
From 2011.igem.org
Line 44: | Line 44: | ||
<TH ROWSPAN=3 BGCOLOR="#A1C6B2"> | <TH ROWSPAN=3 BGCOLOR="#A1C6B2"> | ||
<a name=top></a><p> | <a name=top></a><p> | ||
- | <b><h3> | + | <b><h3>Overview</h3></b> |
<font color=black> | <font color=black> | ||
</p> | </p> | ||
+ | <p > | ||
+ | <h4 align=left><a name=back></a>1. Background </h4> | ||
+ | <a href=#top>[Top]</a> | ||
+ | </p> | ||
- | <p> | + | <p align=justify style="margin: 20px 20px 20px 20px"> |
- | <h4><a name=build></a> | + | |
+ | </p> | ||
+ | |||
+ | |||
+ | <p > | ||
+ | <h4 align=left><a name=build></a>2. Building the horse - Engineering a novel strain for antibiotics-free selection</h4> | ||
</p> | </p> | ||
Line 56: | Line 65: | ||
</p> | </p> | ||
+ | <p > | ||
+ | <h4 align=left>3. The army inside - Toluene-4-Monooxygenase (T4MO)</h4> | ||
+ | </p> | ||
<p align=justify style="margin: 20px 20px 20px 20px"> | <p align=justify style="margin: 20px 20px 20px 20px"> | ||
- | + | Toluene-4-Monooxygenase (T4MO) is a three-component enzyme system that is naturally able to degrade a variety of hydrocarbons. In particular, its ability to oxidize or reduce small aromatic compounds has caught the attention of scientists looking for biological means of producing certain useful organic chemicals for industrial use, resulting in extensive research on modifying its activity and affinity. </p> | |
<p align=justify style="margin: 20px 20px 20px 20px"> | <p align=justify style="margin: 20px 20px 20px 20px"> | ||
- | + | For our project, a mutated form of T4MO (double mutations at G103L & A107G) was chosen as the candidate for indole degradation. While there were several possible candidates, this particular one was known to convert almost 50% of the indole into 7-hydroxyindole (7-HI)[2]. This is of great interest to us as 7-HI has been documented to inhibit biofilm formation in Enterohemorrhagic <i>E. coli</i>[3], and quite possibly for other strains of <i>E. coli</i> as well. Biofilm formation is a major element that reduces the efficiency of antibiotics due to reduced area of action, and hence we were keen to take advantage of this synergistic effect to improve our construct.<a href=#top>[Top]</a> | |
</p> | </p> | ||
- | |||
<p align=justify style="margin: 20px 20px 20px 20px"> | <p align=justify style="margin: 20px 20px 20px 20px"> | ||
- | + | <b><a name=army></a>3.1 Soldiers need shields...maybe - Multidrug Efflux Pump (Bcr)</b> | |
</p> | </p> | ||
<p align=justify style="margin: 20px 20px 20px 20px"> | <p align=justify style="margin: 20px 20px 20px 20px"> | ||
- | + | As our novel strain will have one of its essential genes maintained in a plasmid, a lot of uncertainties are present regarding its fitness. It is quite possible that it will be more vulnerable to antibiotics compared with wild type and thus will be selected against when cultured together with wild type <i>E. coli</i>. This would reduce the effectiveness of our construct and is not desirable. Hence we planed an additional component to be maintained in the plasmid, known as Bcr, which we hope will boost the resistance of E. trojan. You will find more details on its construction <a href=>[here]</a>.<a href=#top>[Top]</a></p> | |
+ | |||
+ | <p align=justify style="margin: 20px 20px 20px 20px"> | ||
</p> | </p> | ||
Line 75: | Line 88: | ||
<hr> | <hr> | ||
<p> | <p> | ||
+ | [1] <a href=http://www.nature.com/nature/journal/v467/n7311/pdf/nature09354.pdf>Bacterial charity work leads to population-wide resistance</a> | ||
+ | <br> | ||
+ | [2] <a href=aem.asm.org/cgi/reprint/71/9/5476.pdf>Mutations of Toluene-4-Monooxygenase That Alter Regiospecificity of Indole Oxidation and Lead to Production of Novel Indigoid Pigments</a> | ||
+ | <br> | ||
+ | [3] <a href=aem.asm.org/cgi/reprint/73/13/4100.pdf>Enterohemorrhagic Escherichia coli Biofilms Are Inhibited by 7-Hydroxyindole and Stimulated by Isatin</a><br><br> | ||
</p> | </p> | ||
Line 88: | Line 106: | ||
<img src=https://static.igem.org/mediawiki/2011/6/6b/Ust_36.jpg width=100 height=100><BR> | <img src=https://static.igem.org/mediawiki/2011/6/6b/Ust_36.jpg width=100 height=100><BR> | ||
+ | <a href=#back>1. Background</a><br> | ||
+ | |||
+ | <a href=#build>2. Building the horse - Engineering a novel strain for antibiotics-free selection</a><br> | ||
- | <a href=# | + | <a href=#army>3. The army inside - Toluene-4-Monooxygenase (T4MO)</a><br> |
</font> | </font> | ||
</p> | </p> |
Revision as of 03:57, 5 October 2011
1. Background[Top]
2. Building the horse - Engineering a novel strain for antibiotics-free selection
3. The army inside - Toluene-4-Monooxygenase (T4MO)Toluene-4-Monooxygenase (T4MO) is a three-component enzyme system that is naturally able to degrade a variety of hydrocarbons. In particular, its ability to oxidize or reduce small aromatic compounds has caught the attention of scientists looking for biological means of producing certain useful organic chemicals for industrial use, resulting in extensive research on modifying its activity and affinity. For our project, a mutated form of T4MO (double mutations at G103L & A107G) was chosen as the candidate for indole degradation. While there were several possible candidates, this particular one was known to convert almost 50% of the indole into 7-hydroxyindole (7-HI)[2]. This is of great interest to us as 7-HI has been documented to inhibit biofilm formation in Enterohemorrhagic E. coli[3], and quite possibly for other strains of E. coli as well. Biofilm formation is a major element that reduces the efficiency of antibiotics due to reduced area of action, and hence we were keen to take advantage of this synergistic effect to improve our construct.[Top] 3.1 Soldiers need shields...maybe - Multidrug Efflux Pump (Bcr) As our novel strain will have one of its essential genes maintained in a plasmid, a lot of uncertainties are present regarding its fitness. It is quite possible that it will be more vulnerable to antibiotics compared with wild type and thus will be selected against when cultured together with wild type E. coli. This would reduce the effectiveness of our construct and is not desirable. Hence we planed an additional component to be maintained in the plasmid, known as Bcr, which we hope will boost the resistance of E. trojan. You will find more details on its construction [here].[Top]
[1] Bacterial charity work leads to population-wide resistance
|
Overview1. Background 2. Building the horse - Engineering a novel strain for antibiotics-free selection 3. The army inside - Toluene-4-Monooxygenase (T4MO) |
---|---|
|
|
|